Document is current
Any future updates will be listed below
-
Authors
Lee, Joon-Kiong https://orcid.org/0000-0002-4215-1689
Leong, Juzaily Fekry https://orcid.org/0000-0002-6870-3234
Thong, Fu-Yuen https://orcid.org/0000-0003-3510-6465
Sharifudin, Mohd Ariff https://orcid.org/0000-0002-6796-2904
Abbas, Azlina Amir https://orcid.org/0000-0003-4423-4653
Kamudin, Nur Azree Ferdaus https://orcid.org/0000-0002-1917-097X
Rampal, Sanjiv https://orcid.org/0000-0001-7047-0903
Yasin, Nor Faissal https://orcid.org/0000-0001-6524-8451
Loh, Kwong-Weng https://orcid.org/0000-0002-2307-8877
Chan, Chee-Ken https://orcid.org/0000-0002-6363-1307
Mitchell, Paul James https://orcid.org/0000-0002-7439-0369
-
Funding
Funding for this research was provided by:
Amgen Biopharmaceuticals Malaysia Sdn. Bhd. (Educational grant)
Zuellig Pharma Malaysia Sdn. Bhd. (Educational grant)
- License Information
-
More Information
Article History
Received: 24 July 2024
Accepted: 8 September 2024
First Online: 21 September 2024
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Dato’ Dr. Joon-Kiong Lee has received honoraria from Amgen, Mylan, and Zuellig Pharma for speaking at symposia, as a member of the advisory board and educational programmes and workshops. Dr. Juzaily Fekry Leong has no conflict of interests. Dr. Fu-Yuen Thong reports no disclosures. Professor Mohd Ariff Sharifudin reports no disclosures. Professor Azlina Amir Abbas reports no disclosures. Dr. Nur Azree Ferdaus Kamudin reports no disclosures. Associate Professor Sanjiv Rampal has received honoraria from Haleon and GSK for speaking at symposia and workshops. Associate Professor Nor Faissal Yasin has no conflict of interests. Dr. Kwong-Weng Loh has no conflict of interests. Dr. Chee-Ken Chan reports no disclosures. Adjunct Professor Paul James Mitchell (PJM) has undertaken consultancy for governments, national and international osteoporosis societies, healthcare professional organisations and private sector companies relating to systematic approaches to fragility fracture care, and prevention since 2005. PJM is a paid consultant for the Malaysian Bone Health Optimization Network (MyBONe).
